lobbying_activities: 1115392

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1115392	4b7319f5-0af1-447a-95a3-108d17f095a2	Q2	W STRATEGIES, LLC	400605842	23ANDME, INC.	2011	second_quarter	MED	Issues relating to FDA regulation of Direct to Consumer Genetic Testing and education and outreach regarding genetic testing and personalized medicine.	Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2011-07-17T13:28:04.440000-04:00